Anti-cancer Drugs : Nature, Synthesis and Cell / / edited by Jasna Bankovic |
Pubbl/distr/stampa | Rijeka, Croatia : , : IntechOpen, , 2016 |
Descrizione fisica | 1 online resource (196 pages) : illustrations |
Disciplina | 616.9 |
Soggetto topico | Liver - Cancer - Treatment |
ISBN |
953-51-7328-6
953-51-2814-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti |
Anti-cancer drugs
Anti-cancer Drugs - Nature, Synthesis and Cell |
Record Nr. | UNINA-9910169207203321 |
Rijeka, Croatia : , : IntechOpen, , 2016 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Clinical dilemmas in primary liver cancer [[electronic resource] /] / edited by Roger Williams, Simon D. Taylor-Robinson |
Pubbl/distr/stampa | Chichester, West Sussex, : John Wiley & Sons, 2012 |
Descrizione fisica | x, 218 p., [7] p. of plates : ill. (some col.), col. map |
Disciplina | 616.99/436 |
Altri autori (Persone) |
WilliamsRoger <1931->
Taylor-RobinsonSimon D |
Soggetto topico |
Liver - Cancer
Liver - Cancer - Diagnosis Liver - Cancer - Treatment |
ISBN |
1-119-96220-X
1-119-96217-X 9786613333148 1-283-33314-7 1-119-96218-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | pt. 1. Learning from a worldwide perspective -- pt. 2. Influence of tumor characteristics -- pt. 3. Complexities of patient assessment and scoring systems -- pt. 4. Choice of radiological diagnostic technique -- pt. 5. Can treatment be tailored to the patient? -- pt. 6. What does the future hold?. |
Record Nr. | UNINA-9910208840903321 |
Chichester, West Sussex, : John Wiley & Sons, 2012 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Clinical dilemmas in primary liver cancer / / edited by Roger Williams, Simon D. Taylor-Robinson |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Chichester, West Sussex, : John Wiley & Sons, 2012 |
Descrizione fisica | x, 218 p., [7] p. of plates : ill. (some col.), col. map |
Disciplina | 616.99/436 |
Altri autori (Persone) |
WilliamsRoger <1931->
Taylor-RobinsonSimon D |
Soggetto topico |
Liver - Cancer
Liver - Cancer - Diagnosis Liver - Cancer - Treatment |
ISBN |
1-119-96220-X
1-119-96217-X 9786613333148 1-283-33314-7 1-119-96218-8 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | pt. 1. Learning from a worldwide perspective -- pt. 2. Influence of tumor characteristics -- pt. 3. Complexities of patient assessment and scoring systems -- pt. 4. Choice of radiological diagnostic technique -- pt. 5. Can treatment be tailored to the patient? -- pt. 6. What does the future hold?. |
Record Nr. | UNINA-9910818185103321 |
Chichester, West Sussex, : John Wiley & Sons, 2012 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Hepatocellular Carcinoma : Challenges and Opportunities of a Multidisciplinary Approach / / edited by Georgios Tsoulfas |
Pubbl/distr/stampa | London : , : IntechOpen, , 2022 |
Descrizione fisica | 1 online resource (202 pages) : illustrations |
Disciplina | 616.9 |
Soggetto topico |
Liver - Cancer - Treatment
Liver - Cancer - Diagnosis |
ISBN | 1-83969-111-5 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Hepatocellular Carcinoma |
Record Nr. | UNINA-9910586642703321 |
London : , : IntechOpen, , 2022 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Immunotherapy in Hepatocellular Carcinoma / / edited by Naoshi Nishida and Masatoshi Kudo |
Pubbl/distr/stampa | [Place of publication not identified] : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2023 |
Descrizione fisica | 1 online resource (274 pages) |
Disciplina | 616.99436 |
Soggetto topico |
Liver - Cancer - Treatment
Liver - Cancer |
ISBN | 3-0365-6690-2 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910719781303321 |
[Place of publication not identified] : , : MDPI - Multidisciplinary Digital Publishing Institute, , 2023 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Malignant liver tumors [[electronic resource] ] : current and emerging therapies / / edited by Pierre-Alain Clavien ; deputy editor, Stefan Breitenstein ; associate editors, Jacques Belghiti ... [et al.] |
Edizione | [3rd ed.] |
Pubbl/distr/stampa | Chichester, West Sussex ; ; Hoboken, NJ, : Blackwell, 2010 |
Descrizione fisica | 1 online resource (576 p.) |
Disciplina | 616.99436 |
Altri autori (Persone) |
ClavienPierre-Alain
Abou-AlfaGhassan (MSKCC.) CassilethBarrie R (MSKCC.) DaiMenghua (MSKCC.) FongYuman (MSKCC.) GonzalezLorena (MSKCC.) GubiliJyothirmai (MSKCC.) KemenyNancy (MSKCC.) |
Soggetto topico |
Liver - Cancer - Treatment
Oncology |
Soggetto genere / forma | Electronic books. |
ISBN |
1-282-38511-9
9786612385117 1-4443-1705-9 1-4443-1706-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Malignant Liver Tumors: Current and Emerging Therapies, THIRD EDITION; Contents; Contributors; Preface; Acknowledgments; Abbreviations; Section 1: Introduction; Section 2: Epidemiology and Diagnosis; Section 3: Systemic and Regional Therapies; Section 4: Resection, Ablation or Transplantation for Liver Tumors; Section 5: Guidelines for Liver Tumor Treatment; Section 6: Emerging Therapies; Section 7: Special Tumors, Population, and Special Considerations; Index |
Record Nr. | UNINA-9910139970803321 |
Chichester, West Sussex ; ; Hoboken, NJ, : Blackwell, 2010 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Malignant liver tumors [[electronic resource] ] : current and emerging therapies / / edited by Pierre-Alain Clavien ; deputy editor, Stefan Breitenstein ; associate editors, Jacques Belghiti ... [et al.] |
Edizione | [3rd ed.] |
Pubbl/distr/stampa | Chichester, West Sussex ; ; Hoboken, NJ, : Blackwell, 2010 |
Descrizione fisica | 1 online resource (576 p.) |
Disciplina | 616.99436 |
Altri autori (Persone) |
ClavienPierre-Alain
Abou-AlfaGhassan (MSKCC.) CassilethBarrie R (MSKCC.) DaiMenghua (MSKCC.) FongYuman (MSKCC.) GonzalezLorena (MSKCC.) GubiliJyothirmai (MSKCC.) KemenyNancy (MSKCC.) |
Soggetto topico |
Liver - Cancer - Treatment
Oncology |
ISBN |
1-282-38511-9
9786612385117 1-4443-1705-9 1-4443-1706-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Malignant Liver Tumors: Current and Emerging Therapies, THIRD EDITION; Contents; Contributors; Preface; Acknowledgments; Abbreviations; Section 1: Introduction; Section 2: Epidemiology and Diagnosis; Section 3: Systemic and Regional Therapies; Section 4: Resection, Ablation or Transplantation for Liver Tumors; Section 5: Guidelines for Liver Tumor Treatment; Section 6: Emerging Therapies; Section 7: Special Tumors, Population, and Special Considerations; Index |
Record Nr. | UNISA-996214693803316 |
Chichester, West Sussex ; ; Hoboken, NJ, : Blackwell, 2010 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. di Salerno | ||
|
Malignant liver tumors [[electronic resource] ] : current and emerging therapies / / edited by Pierre-Alain Clavien ; deputy editor, Stefan Breitenstein ; associate editors, Jacques Belghiti ... [et al.] |
Edizione | [3rd ed.] |
Pubbl/distr/stampa | Chichester, West Sussex ; ; Hoboken, NJ, : Blackwell, 2010 |
Descrizione fisica | 1 online resource (576 p.) |
Disciplina | 616.99436 |
Altri autori (Persone) |
ClavienPierre-Alain
Abou-AlfaGhassan (MSKCC.) CassilethBarrie R (MSKCC.) DaiMenghua (MSKCC.) FongYuman (MSKCC.) GonzalezLorena (MSKCC.) GubiliJyothirmai (MSKCC.) KemenyNancy (MSKCC.) |
Soggetto topico |
Liver - Cancer - Treatment
Oncology |
ISBN |
1-282-38511-9
9786612385117 1-4443-1705-9 1-4443-1706-7 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Malignant Liver Tumors: Current and Emerging Therapies, THIRD EDITION; Contents; Contributors; Preface; Acknowledgments; Abbreviations; Section 1: Introduction; Section 2: Epidemiology and Diagnosis; Section 3: Systemic and Regional Therapies; Section 4: Resection, Ablation or Transplantation for Liver Tumors; Section 5: Guidelines for Liver Tumor Treatment; Section 6: Emerging Therapies; Section 7: Special Tumors, Population, and Special Considerations; Index |
Record Nr. | UNINA-9910829990303321 |
Chichester, West Sussex ; ; Hoboken, NJ, : Blackwell, 2010 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Nanotherapeutics for the Treatment of Hepatocellular Carcinoma |
Autore | Mukherjee Biswajit |
Pubbl/distr/stampa | Singapore : , : Bentham Science Publishers, , 2022 |
Descrizione fisica | 1 online resource (557 pages) |
Disciplina | 616.99436 |
Soggetto topico | Liver - Cancer - Treatment |
Soggetto non controllato |
Oncology
Medical |
ISBN | 981-5039-74-1 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- Hepatocellular Carcinoma: Diagnosis, Molecular Pathogenesis, Biomarkers, and Conventional Therapy -- Biswajit Mukherjee*, 1, Manasadeepa Rajagopalan2, Samrat Chakraborty1, Prasanta Ghosh1, Manisheeta Ray1, Ramkrishna Sen1 and Iman Ehsan1 -- INTRODUCTION -- CANCER AND ITS TYPES -- Primary Liver Cancer -- Hepatocellular Carcinoma (HCC) -- Intrahepatic Cholangiocarcinoma (Bile Duct Cancer) -- Angiosarcoma and Hemangiosarcoma -- Hepatoblastoma -- Secondary Liver Cancer Surgical Resection in Advanced HCC -- Anatomical Resection -- Laparoscopic Resection of The Liver -- Surgical Resection of Re-Occurring HCC -- Liver Transplantation -- Ablation -- Palliative Treatment -- Embolizing Therapies for HCC -- Transarterial Chemoembolization (TACE) -- Radiotherapy -- Systemic Therapies of HCC -- First-line Therapy -- Second-line Therapy -- Multi-Target Tyrosine Kinase Inhibitors -- Immune Checkpoint Inhibitor -- FUTURE PERSPECTIVES -- CONCLUSIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES DETAIL DESCRIPTION OF HCC -- Staging System in HCC -- Risk Factors for HCC -- Pathophysiology of HCC -- Molecular and Cellular Features of the Tumor Microenvironment -- Importance of Cancer Stem Cells in HCC -- Inflammation and HCC -- Oxidative Stress in HCC -- Epithelial-Mesenchymal Transition (EMT) -- Hypoxia and HCC -- Impairment of Cell Cycle in HCC -- Loss of Senescence Control -- Apoptosis and HCC -- Cellular Signalling Pathways in HCC -- EGF/TGF-a pathway -- Insulin Growth Factor (IGF) Pathway -- HGF/c-Met Pathway -- Signaling Pathways Involved in Neovascularization in HCC -- MAPK Pathways PI3K/Akt/mTOR Pathway -- Signaling Pathways Related to Cell Differentiation and Development -- Wnt-ß Catenin Pathway -- Hedgehog (Hh) Signaling -- Notch Pathway -- Hippo Pathway -- Target Receptor(s) and Biomarker Proteins in HCC -- Asialoglycoprotein Receptor -- Glypican-3 (GPC3) -- Transferrin Receptor (TfR) -- Heat Shock Protein 70 (HSP70) -- Tumor-Associated Glycoprotein-72 (TAG-72) -- Golgi Protein73 (GP73) -- Ki-67 Antigen -- Somatostatin Receptor (SSTR) -- Homodimeric Glycoprotein (AF-20) -- Osteopontin (OPN) -- Des-?-Carboxyprothrombin -- a-Fetoprotein (AFP) Squamous Cell Carcinoma Antigen (SCCA) -- Hepatocyte Paraffin 1 (HepPar1) -- APO-J -- DKK-1 (Dickkopf-p1) -- Human Carbonyl Reductase 2 (HCR2) -- Midkine -- Nerve Growth Factor (NGF) -- Vascular Endothelial Growth Factor (VEGF) -- Transforming Growth Factor-ß (TGF-ß) -- Epidermal Growth Factor (EGFR) -- Hepatocyte Growth Factor (HGF) -- a-1-Fucosidase -- Annexin A2 -- Micro RNA -- Circular RNAs -- Cancer Stem Markers -- CD44 -- CD133 -- CD90 -- Epithelial Cell Adhesion Molecule (EpCAM) -- SURVEILLANCE AND HCC -- TREATMENT STRATEGIES -- Curative Treatments -- Surgical Resection. |
Record Nr. | UNINA-9910795155203321 |
Mukherjee Biswajit | ||
Singapore : , : Bentham Science Publishers, , 2022 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Nanotherapeutics for the Treatment of Hepatocellular Carcinoma |
Autore | Mukherjee Biswajit |
Pubbl/distr/stampa | Singapore : , : Bentham Science Publishers, , 2022 |
Descrizione fisica | 1 online resource (557 pages) |
Disciplina | 616.99436 |
Soggetto topico | Liver - Cancer - Treatment |
Soggetto non controllato |
Oncology
Medical |
ISBN | 981-5039-74-1 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- Hepatocellular Carcinoma: Diagnosis, Molecular Pathogenesis, Biomarkers, and Conventional Therapy -- Biswajit Mukherjee*, 1, Manasadeepa Rajagopalan2, Samrat Chakraborty1, Prasanta Ghosh1, Manisheeta Ray1, Ramkrishna Sen1 and Iman Ehsan1 -- INTRODUCTION -- CANCER AND ITS TYPES -- Primary Liver Cancer -- Hepatocellular Carcinoma (HCC) -- Intrahepatic Cholangiocarcinoma (Bile Duct Cancer) -- Angiosarcoma and Hemangiosarcoma -- Hepatoblastoma -- Secondary Liver Cancer Surgical Resection in Advanced HCC -- Anatomical Resection -- Laparoscopic Resection of The Liver -- Surgical Resection of Re-Occurring HCC -- Liver Transplantation -- Ablation -- Palliative Treatment -- Embolizing Therapies for HCC -- Transarterial Chemoembolization (TACE) -- Radiotherapy -- Systemic Therapies of HCC -- First-line Therapy -- Second-line Therapy -- Multi-Target Tyrosine Kinase Inhibitors -- Immune Checkpoint Inhibitor -- FUTURE PERSPECTIVES -- CONCLUSIONS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENT -- REFERENCES DETAIL DESCRIPTION OF HCC -- Staging System in HCC -- Risk Factors for HCC -- Pathophysiology of HCC -- Molecular and Cellular Features of the Tumor Microenvironment -- Importance of Cancer Stem Cells in HCC -- Inflammation and HCC -- Oxidative Stress in HCC -- Epithelial-Mesenchymal Transition (EMT) -- Hypoxia and HCC -- Impairment of Cell Cycle in HCC -- Loss of Senescence Control -- Apoptosis and HCC -- Cellular Signalling Pathways in HCC -- EGF/TGF-a pathway -- Insulin Growth Factor (IGF) Pathway -- HGF/c-Met Pathway -- Signaling Pathways Involved in Neovascularization in HCC -- MAPK Pathways PI3K/Akt/mTOR Pathway -- Signaling Pathways Related to Cell Differentiation and Development -- Wnt-ß Catenin Pathway -- Hedgehog (Hh) Signaling -- Notch Pathway -- Hippo Pathway -- Target Receptor(s) and Biomarker Proteins in HCC -- Asialoglycoprotein Receptor -- Glypican-3 (GPC3) -- Transferrin Receptor (TfR) -- Heat Shock Protein 70 (HSP70) -- Tumor-Associated Glycoprotein-72 (TAG-72) -- Golgi Protein73 (GP73) -- Ki-67 Antigen -- Somatostatin Receptor (SSTR) -- Homodimeric Glycoprotein (AF-20) -- Osteopontin (OPN) -- Des-?-Carboxyprothrombin -- a-Fetoprotein (AFP) Squamous Cell Carcinoma Antigen (SCCA) -- Hepatocyte Paraffin 1 (HepPar1) -- APO-J -- DKK-1 (Dickkopf-p1) -- Human Carbonyl Reductase 2 (HCR2) -- Midkine -- Nerve Growth Factor (NGF) -- Vascular Endothelial Growth Factor (VEGF) -- Transforming Growth Factor-ß (TGF-ß) -- Epidermal Growth Factor (EGFR) -- Hepatocyte Growth Factor (HGF) -- a-1-Fucosidase -- Annexin A2 -- Micro RNA -- Circular RNAs -- Cancer Stem Markers -- CD44 -- CD133 -- CD90 -- Epithelial Cell Adhesion Molecule (EpCAM) -- SURVEILLANCE AND HCC -- TREATMENT STRATEGIES -- Curative Treatments -- Surgical Resection. |
Record Nr. | UNINA-9910810523403321 |
Mukherjee Biswajit | ||
Singapore : , : Bentham Science Publishers, , 2022 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|